Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases$1. .$1
Infectious Diseases, Biodefense, Vaccine Manufacturing and Vaccines
201 - 500
💰 $200M Post-IPO Debt on 2021-05
5 hours ago
201 - 500
Senior Analyst using data analytics to enhance commercial functions at Dynavax's innovative vaccine company.
🇺🇸 United States – Remote
💵 $74.5k - $86k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟠 Senior
🧐 Analyst
November 12
201 - 500
Enable Dynavax’s strategic business and licensing transactions for vaccines.
🇺🇸 United States – Remote
💵 $267k - $295k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟠 Senior
👔 Director
October 2
201 - 500
Lead global IT strategies for Dynavax's biopharmaceutical technology.
🇺🇸 United States – Remote
💵 $300k - $333k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🔴 Lead
👔 Vice President